Wednesday, February 15, 2012

Café au lait spots

Café au lait (French pronunciation: [kafe o lɛ] "coffee with milk") is a French coffee drink. 
Are so called because the spots are light brown in color ( like coffee with milk)
They are pigmented birthmarks.  The spots of neurofibromatosis,  have a smooth border resembling the "coast of California"


Having six or more café au lait spots greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, is a diagnostic feature of neurofibromatosis type I, but other features are required to diagnose NF-1. The incidence of single lesions is high and of no significance - a patient is allowed up to four patches of less than 0.5cm diameter, but no patches greater than 1.5cm diameter.


Café au lait spots: In McCune-Albright's syndrome WILL NOT CROSS THE MIDLINE has a irregular border compared to "Coast of Maine"The patches are usually large, and have irregular borders resembling the "coast of Maine". .
Typical lesions that are often found on the nape of the neck and crease of the buttocks are shown (arrows).
Picture Courtesy: Wikkipedia

Tuesday, February 14, 2012

Thyroid Antibodies


Thyroid peroxidase or thyroperoxidase (TPO) is an enzyme expressed mainly in the thyroid that liberates iodine for addition onto tyrosine residues on thyroglobulin for the production of thyroxine (T4) ortriiodothyronine (T3), thyroid hormones. In humans, thyroperoxidase is encoded by the TPO gene.
Thyroid peroxidase is a frequent epitope of autoantibodies in autoimmune thyroid disease, with such antibodies being called anti-thyroid peroxidase antibodies (anti-TPO antibodies).


THYROID ANTIBODYACRONYMPRESENT INWHEN ORDEREDOTHER FACTS
Thyroid peroxidase antibodyTPOAbHashimoto thyroiditis;Graves diseaseWhen patient has symptoms suggesting hypothyroidism; when considering starting a patient on a drug therapy that has associated risks of developing hypothyroidism when thyroid peroxidase antibodies are present, such as lithium, amiodarone, interferon alpha, or interleukin-2Has been associated with reproductive difficulties, such as miscarriage,preeclampsia, premature delivery, and in-vitro fertilization failure
Thyroglobulin antibodyTgAbThyroid cancer; Hashimoto thyroiditisWhenever a thyroglobulin test is performed to see if the antibody is present and likely to be interfering with the test results; since the thyroglobulin test will be ordered at regular intervals after thyroid cancer treatment, thyroglobulin antibody will also be ordered at regular intervals 
Thyroid stimulating hormone receptor antibodyTRAbGraves diseaseWhen patient has symptoms of hyperthyroidism; to monitor effectiveness of anti-thyroid therapy 

Monday, February 13, 2012

Wolff–Parkinson–White syndrome

Wolff-Parkinson-White syndrome is a heart condition in which there is an extra electrical pathway (circuit) in the heart. The condition can lead to episodes of rapid heart rate
Wolff-Parkinson-White is one of the most common causes of fast heart rate disorders in infants and children.
In people with Wolff-Parkinson-White syndrome, there is an extra, or accessory, pathway that may cause a very rapid heart rate. This is called supraventricular tachycardia.
ECG  may show an abnormality called a "delta" wave. ( see the short PR interval)

Intracardiac electrophysiology study (EPS) : May be needed sometimes to make the diagnosis. The study involves placing wire electrodes in the heart to check for abnormal heartbeats or heart rhythms.

Medication may be used to control or prevent rapid heart beating. These include adenosine, antiarrhythmics, and amiodarone.

 electricalcardioversion may be needed in some
The current preferred therapy for Wolff-Parkinson-White syndrome is catheter ablation (success rate for the procedure ranges between 85 - 95%). The small area that is causing the fast heart rate is destroyed using radiofrequency.
Rarely surgery is needed

 Success rate of Catheter ablation will vary depending on location of accessory pathway and number of accessory pathways.


Courtesy: http://en.wikipedia.org/wiki/Wolff%E2%80%93Parkinson%E2%80%93White_syndrome, http://www.nlm.nih.gov/medlineplus/ency/article/000151.htm AND http://pedicardiology-bala.blogspot.com/2011/08/ekg-wpw-syndrome.html

Sunday, February 12, 2012

Major Depressive Disorder in Children and Adolescents

Source: http://www.uspreventiveservicestaskforce.org/uspstf/uspschdepr.htm#summary
U.S. Preventive Services Task Force (USPSTF) recommendations on screening for depression in children and adolescents





Summary of Recommendations

  • The USPSTF recommends screening of adolescents (12-18 years of age) for major depressive disorder (MDD) when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and follow-up. 
  • The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening of children (7-11 years of age).
  • Benefits of Detection and Early Intervention
    • Adolescents (12-18 years of age): The USPSTF found adequate evidence that treatment in adolescents with selective serotonin reuptake inhibitors (SSRIs -  fluoxetine) ), psychotherapy, and combined therapy (SSRIs and psychotherapy) results in decreases in MDD symptoms.
    • Children (7-11 years of age): The USPSTF found inadequate evidence to support the benefits of treatment in children. SSRIs (fluoxetine) reduce MDD symptoms in children; however, there are limited data on the benefits of psychotherapy and the benefits of psychotherapy plus SSRIs in children.
  • Assessment of Risk: Important risk factors that can be assessed relatively accurately and reliably include parental depression, having comorbid mental health or chronic medical conditions, and having experienced a major negative life event.

Screening Tests: Instruments developed for primary care (Patient Health Questionnaire for Adolescents [PHQ-A] and the Beck Depression Inventory-Primary Care Version [BDI-PC]) have been used successfully in adolescents. 
There are limited data describing the accuracy of using MDD screening instruments in younger children (7-11 years of age).
Treatment: Among pharmacotherapies available for the treatment of MDD in children and adolescents, SSRIs have been found to be efficacious. Treating depressed youth with SSRIs is associated with an increased risk of suicidality and, therefore, should only be considered if judicious clinical monitoring is possible. Psychotherapy trials indicate that a variety of psychotherapy types are efficacious among adolescents (including cognitive-behavioral and interpersonal therapies). Harms of psychotherapy are felt to be small.

Update of Previous USPSTF Recommendation

This recommendation updates the previous recommendation released in 2002. The major change in the current recommendation is that the USPSTF now recommends screening of adolescents (12-18 years of age) for MDD when systems are in place to ensure accurate diagnosis, psychotherapy (eg, cognitive-behavioral, interpersonal), and follow-up. In 2002, the USPSTF concluded that there was insufficient evidence to recommend for or against routine screening of children or adolescents for MDD (I recommendation). The basis for this change in recommendation for adolescents is a result of new evidence that demonstrates treatment benefit.

Saturday, February 11, 2012

Glomerulonephritis (gloe-mer-u-lo-nuh-FRY-tis)

Glomerulonephritis, is a renal disease (usually of both kidneys) characterized by inflammation of the glomeruli, or small blood vessels in the kidneys.
It may present with isolated hematuria and/or proteinuria.
Presenting picture can be nephrotic syndrome, a nephritic syndrome, acute renal failure, or chronic renal failure.
Broadly grouped into non-proliferative or proliferative types.
Diagnosing the pattern of GN is important because the outcome and treatment differs in different types.
Primary causes are ones which are intrinsic to the kidney, whilst secondary causes are associated with certain infections (bacterial, viral or parasitic pathogens), drugs, systemic disorders (SLE, vasculitis) or diabetes.

Non Proliferative
This is characterised by the numbers of cells (lack of hypercellularity) in the glomeruli. They usually cause nephrotic syndrome. This has the following types:

Minimal change GN (also known as Minimal Change Disease)
The three hallmarks of Minimal Change Disease: diffuse loss of podocyte foot processes, vacuolation, and the appearance of microvilli.

This form of GN causes >75% of nephrotic syndrome in children, but only ~20% in adults. There are no changes visible on simple light microscopy, but on electron microscopy there is fusion of podocytes (supportive cells in the glomerulus).
Immunohistochemistry staining is negative.
Treatment consists of supportive care for the massive edema and as well as steroids to halt the disease process (typically Prednisone 1 mg/kg). Over 90% of children respond well to steroids, being essentially cured after 3 months of treatment.
Adults have a lower response rate (80%).
Failure to respond to steroids ('steroid resistant') or return of the disease when steroids are stopped ('steroid dependent') may require cytotoxic therapy (such as cyclosporin) which is associated with many side-effects.

Other 2 typs with nonproliferative are Focal Segmental GN and Membranous glomerulonephritis.


Proliferative Glomerulonephritis
This type is characterised by increased number of cells in the glomerulus (hypercellular). Usually present as a nephritic syndrome and usually progress to end-stage renal failure (ESRF) over weeks to years (depending on type).

Courtesy: http://en.wikipedia.org/wiki/Minimal_change_disease and Mayo Clinic

Friday, February 10, 2012

Interpretation of Hepatitis B Serologic Test Results

Hepatitis B serologic testing involves measurement of several hepatitis B
virus (HBV)-specifi c antigens and antibodies. Different serologic “markers”
or combinations of markers are used to identify different phases of HBV
infection and to determine whether a patient has acute or chronic HBV
infection, is immune to HBV as a result of prior infection or vaccination, or
is susceptible to infection.
Hepatitis B surface antigen (HBsAg):
A protein on the surface of hepatitis B virus; it can be detected in high levels in serum during acute or chronic hepatitis B virus infection. The presence of HBsAg indicates that the person is infectious. The body normally produces antibodies to HBsAg as part of the normal immune response to infection. HBsAg is the antigen used to make hepatitis B vaccine.

Hepatitis B surface antibody (anti-HBs):
The presence of anti-HBs is generally interpreted as indicating recovery and immunity from hepatitis B virus infection. Anti-HBs also develops in a person who has been successfully vaccinated against hepatitis B

Total hepatitis B core antibody (anti-HBc):
Appears at the onset of symptoms in acute hepatitis B and persists for life. The presence of
anti-HBc indicates previous or ongoing infection with hepatitis B virus in an undefined time frame

IgM antibody to hepatitis B core antigen (IgM anti-HBc):
Positivity indicates recent infection with hepatitis B virus (<6 mos). Its presence indicates acute infection.
Tests Results Interpretation


Susceptible
HBsAg negative
anti-HBc negative
anti-HBs negative

Immune due to natural infection
HBsAg negative
anti-HBc positive
anti-HBs positive

Immune due to hepatitis B vaccination
HBsAg negative
anti-HBc negative
anti-HBs positive

Acutely infected

HBsAg positive
anti-HBc positive
IgM anti-HBc positive
anti-HBs negative

Chronically infected
HBsAg positive
anti-HBc positive
IgM anti-HBc negative
anti-HBs negative

Interpretation unclear; four possibilities:
1. Resolved infection (most common)
2. False-positive anti-HBc, thus susceptible
3. “Low level” chronic infection
4. Resolving acute infection

anti-HBs negative
HBsAg negative
anti-HBc positive
Adapted from: A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B
Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization
Practices. Part I: Immunization of Infants, Children, and Adolescents. MMWR 2005;54(No. RR-16


Courtesy: http://www.cdc.gov/hepatitis/HBV/PDFs/SerologicChartv8.pdf

Thursday, February 9, 2012

Interesting Appendix!

One of the most common causes of severe acute abdominal pain worldwide.
A correctly diagnosed non-acute form of appendicitis is known as "rumbling appendicitis".
The term "pseudoappendicitis" is used to describe a condition mimicking appendicitis. It can be associated with Yersinia enterocolitica.


Picture shows an acutely inflamed and enlarged appendix, sliced lengthwise.

Rovsing's sign
Continuous deep palpation starting from the left iliac fossa upwards (counterclockwise along the colon) may cause pain in the right iliac fossa, by pushing bowel contents towards the ileocaecal valve and thus increasing pressure around the appendix.

Psoas sign or "Obraztsova's sign"
is right lower-quadrant pain that is produced with either the passive extension of the patient's right hip (patient lying on left side, with knee in flexion) or by the patient's active flexion of the right hip while supine. The pain elicited is due to inflammation of the peritoneum overlying the iliopsoas muscles and inflammation of the psoas muscles themselves. Straightening out the leg causes pain because it stretches these muscles, while flexing the hip activates the iliopsoas and therefore also causes pain.

Obturator sign
If an inflamed appendix is in contact with the obturator internus, spasm of the muscle can be demonstrated by flexing and internal rotation of the hip. This maneuver will cause pain in the hypogastrium.

Dunphy's sign
Increased pain in the right lower quadrant with coughing

Kocher's (Kosher's) sign
From the history given, the appearance of pain in the epigastric region or around the stomach at the beginning of disease with a subsequent shift to the right iliac region.

Differential diagnosis
In children
Gastroenteritis, mesenteric adenitis, Meckel's diverticulitis, intussusception, Henoch-Schönlein purpura, lobar pneumonia, urinary tract infection, new-onset Crohn's disease or ulcerative colitis, pancreatitis, abdominal trauma from child abuse, distal intestinal obstruction syndrome in children with cystic fibrosis, typhlitis in children with leukemia;

Courtesy: Wikipedia: http://en.wikipedia.org/wiki/Appendicitis

Wednesday, February 8, 2012

Neonatal Diabetes



Disease characteristics. Permanent neonatal diabetes mellitus (PNDM) is characterized by the onset of hyperglycemia within the first six months of life (mean age: 7 weeks; range: birth to 26 weeks) that does not resolve over time. Clinical manifestations at the time of diagnosis include intrauterine growth retardation (IUGR); hyperglycemia, glycosuria, osmotic polyuria, severe dehydration, and failure to thrive.


Approximately 20% of individuals with mutations in KCNJ11 have associated neurologic findings, called the DEND syndrome (developmental delay, epilepsy, and neonatal diabetes mellitus)


a milder form without seizures and with less severe developmental delay is called intermediate DEND syndrome


Pancreatic hypoplasia caused by homozygous PDX1 mutations results in severe insulin deficiency and exocrine pancreatic insufficiency.


Management. Treatment of manifestations: Start rehydration and intravenous insulin 






The five genes currently known to be associated with nonsyndromic PNDM (Autosomal Dominant) are KCNJ11(~30% of PNDM), ABCC8 (~19%), INS (~20%), GCK (~4%), and PDX1 (<1%). Molecular genetic testing is available on a clinical basis for all genes
Some Autosomal Recessive Mutations also exist
Prenatal counselling needs to be done in affected families


Courtesy: http://www.ncbi.nlm.nih.gov/books/NBK1447/


Image courtesy: http://diabetes.diabetesjournals.org/content/57/11/2889.full

.

Tuesday, February 7, 2012

Neonatal pustular melanosis or Transient Neonatal pustular melanosis

Other Terminologies:
1.Transient neonatal pustulosis
2.Transient Neonatal pustular melanosis
3.Lentigines neonatorum


It is a benign cutaneous condition that presents at birth with 1- to 3-mm flaccid, superficial fragile pustules, some of which may have already resolved in utero, leaving pigmented macules.

It has distinctive features characterized by vesicles, superficial pustules, and pigmented macules. The lesions of transient neonatal pustular melanosis are present at birth.

Commonly seen: On the chin, neck, forehead, chest, buttocks, back, and on the palms and soles

Self resolves in about 2 days. More common in dark skinned neonates.

Diagnosis: Usually Clinical. A Tzanck smear with a cellular stain (eg, Wright-Giemsa stain) or Gram stain of the contents of a pustule reveals a predominance of neutrophils and occasional eosinophils and cellular debris

Image Courtesy: DermAtlas

Monday, February 6, 2012

Tetralogy of Fallot

Picture Courtesy: American Heart Association
The classic form includes four defects of the heart and its major blood vessels:
  • Ventricular septal defect (hole between the right and left ventricles)
  • Narrowing of the pulmonary outflow tract (the valve and artery that connect the heart with the lungs)
  • Overriding aorta (the artery that carries oxygen-rich blood to the body) that is shifted over the right ventricle and ventricular septal defect, instead of coming out only from the left ventricle
  • Thickened wall of the right ventricle (right ventricular hypertrophy
    Factors that increase the risk for this condition during pregnancy include:
    • Alcoholism in the mother
    • Diabetes
    • Mother who is over 40 years old
    • Poor nutrition during pregnancy
    • Rubella or other viral illnesses during pregnancy


      Surgery is now often carried out in infants one year of age or younger with less than 5% perioperative mortality. The open-heart surgery is designed (1) to relieve the right ventricular outflow tract stenosis by careful resection of muscle and (2) to repair the VSD with a Gore-Tex patch or a homograft. Additional reparative or reconstructive surgery may be done on patients as required by their particular cardiac anatomy. (courtesy Wikipedia)

Sunday, February 5, 2012

LEUKOTRIENE MODIFIERS


Picture Courtesy: Healthy Palm



Leukotrienes are fatty signaling molecules. They were first found in leukocytes (hence their name). One of their roles (specifically, leukotriene D4) is to trigger contractions in the smooth muscles lining the trachea; their overproduction is a major cause of inflammation in asthma and allergic rhinitis.


Leukotrienes act principally on a subfamily of G protein-coupled receptors. They may also act upon peroxisome proliferator-activated receptors. Leukotrienes are involved in asthmatic and allergic reactions and act to sustain inflammatory reactions. Several leukotriene receptor antagonists such as montelukast and zafirlukast are used to treat asthma. Recent research points to a role of 5-lipoxygenase in cardiovascular and neuropsychiatric illnesses
Courtesy: http://en.wikipedia.org/wiki/Leukotriene





SOME BRAND NAMES OF LEUKOTRIENE MODIFIERS (Generic names in parentheses)
Singulair (Montelukast Sodium) Approved for children 2 and older
Accolate(Zafirlukast) Approved for children 7 and older
Zyflo (Zileuton) Not approved for children
Courtesy: NY State Government :http://www.nyc.gov/html/doh/downloads/pdf/asthma/leuko.pdf

The National Institutes of Health (NIH): national asthma guidelines:
1. Inhaled corticosteroids are the most effective anti-inflammatory medications for long-term management of persistent asthma.
2.    All people with asthma should receive a written Asthma Action Plan.
3.    All patients should have an initial assessment that covers impairment and risk to determine the level of therapy needed.
4.    At planned follow-up visits, asthma patients should review their level of control with their healthcare provider based on multiple measures of current impairment and future risk in order to guide clinician decisions to either maintain or adjust therapy.
5.    Patients who have asthma should be scheduled for planned follow-up visits at periodic intervals in order to assess their asthma control and modify treatment, if needed.
6.    Clinicians should review each patient’s exposure to allergens and irritants and provide a multi-pronged strategy to reduce exposure to those allergens and irritants that make a patient’s asthma worse.


Saturday, February 4, 2012

INSULIN - DEGLUDEC - The new insulin - yet to hit the market...




Insulin degludec (IDeg) is a new basal insulin that forms soluble multihexamer assemblies after subcutaneous injection, resulting in an ultra-long action profile.

Degludec has an action duration of more than 24 hours.


Friday, February 3, 2012

RASopathy - What are they?

The RAS pathway is a part of the body that regulates each person's growth and function. It is critical to each person's normal, early development. If this pathway is disrupted by a genetic change in a child's development, there can be a variety of symptoms, including skin changes, heart defects, problems with muscles, bones, eyesight and learning abilities. In some cases, there is an increased risk of developing tumors or cancer.


The RASopathies are developmental syndromes caused by germline mutations in genes that alter the Ras subfamily and Mitogen-activated protein kinase that control Signal transduction


Examples:

  • Capillary malformation-AV malformation syndrome
  • Autoimmune lymphoproliferative syndrome
  • Costello syndrome
  • Hereditary Gingival fibromatosis type 1
  • Legius syndrome
  • LEOPARD syndrome
  • Neuro-cardio-facial-cutaneous syndromes
  • Neurofibromatosis type 1
  • Noonan syndrome

Courtesy: Wikkipedia and Univ of Wisconsin

Thursday, February 2, 2012

Diphtheria



Caused by Corynebacterium diphtheriae.
The bacteria most commonly infects the nose and throat. The throat infection causes a gray to black, tough, fiber-like covering, which can block the airways. In some cases, diphtheria may first infect the skin, producing skin lesions.

Signs and tests

The health care provider will perform a physical exam and look inside your mouth. This may reveal a gray to black covering (pseudomembrane) in the throat, enlarged lymph glands, and swelling of the neck or larynx.

Tests used may include:
Gram stain or throat culture to identify Corynebacterium diphtheriae
Electrocardiogram (ECG)

Treatment

If the health care provider thinks you have diphtheria, treatment should be started immediately, even before test results are available.

Diphtheria antitoxin is given as a shot into a muscle or through an IV (intravenous line). The infection is then treated with antibiotics, such as penicillin and erythromycin.

The death rate is 10%

Complications

The most common complication is inflammation of the heart muscle (myocarditis). The nervous system is also frequently and severely affected, which may result in temporary paralysis.

The diphtheria toxin can also damage the kidneys.

Courtesy of Centers for Disease Control and Prevention AND NIH

Wednesday, February 1, 2012

Tuberous Sclerosis - An overview

The name, composed of the Latin tuber (swelling) and the Greek skleros (hard)



Tuberous sclerosis is inherited in an autosomal dominant pattern of inheritance, and penetrance is variable.

In infants, the first clue is often the presence of seizures, delayed development or white patches on the skin.
A full clinical diagnosis involves
Taking a personal and family history.
Examining the skin under a Wood's lamp (hypomelanotic macules), the fingers and toes (ungual fibroma), the face (angiofibromas) and the mouth (dental pits and gingival fibromas).
Cranial imaging with non enhanced CT or, preferably, MRI (cortical tubers and subependymal nodules).
Renal ultrasound (angiomyolipoma or cysts).
An echocardiogram in infants (rhabdomyoma).
Fundoscopy (retinal nodular hamartomas or achromic patch).
The various signs are then marked against the diagnostic criteria to produce a level of diagnostic certainty:
Definite – Either two major features or one major feature plus two minor features.
Probable – One major plus one minor feature.
Suspect – Either one major feature or two or more minor features.
Due to the wide variety of mutations leading to TSC, there are no simple genetic tests available to identify new cases. Nor are there any biochemical markers for the gene defects.
However, once a person has been clinically diagnosed, the genetic mutation can usually be found. The search is time-consuming and has a 15% failure rate, which is thought to be due to somatic mosaicism. If successful, this information can be used to identify affected family members, including prenatal diagnosis. As of 2006, preimplantation diagnosis is not widely available.

Thankyou Wikipedia!

Tuesday, January 31, 2012

Respiratory Syncytial Virus Infection (RSV)

Respiratory syncytial (sin-SISH-uhl) virus

ost clinical laboratories currently utilize antigen detection tests, and many supplement antigen testing with cell culture. Compared with culture, the sensitivity of antigen detection tests generally ranges from 80% to 90%. Antigen detection tests and culture are generally reliable in young children but less useful in older children and adults. Because of its thermolability, the sensitivity of RSV isolation in cell culture from respiratory secretions can vary among laboratories. Experienced laboratorians should be consulted for optimal results.

RT-PCR assays are now commercially available for RSV. The sensitivity of these assays often exceeds the sensitivity of virus isolation and antigen detections methods. Use of highly sensitive RT-PCR assays should be considered, particularly when testing older children and adults because they may have low viral loads in their respiratory specimens.

Serologic tests are less frequently used for routine diagnosis. Although useful for seroprevalence and epidemiologic studies, a diagnosis using paired acute- and convalescent-phase sera to demonstrate a significant rise in antibody titer to RSV cannot be made in time to guide patient care.

American Academy of Pediatrics (AAP) Guidelines for Infants and Children at Risk for Severe Illness Due to RSV Infection

According to the AAP1, palivizumab prophylaxis may be considered for the following infants and children

Infants born at 28 weeks’ gestation or earlier during RSV season, whenever that occurs during the first 12 months of life
Infants born at 29–32 weeks’ gestation if they are younger than 6 months of age at the start of the RSV season
Infants born at 32–35 weeks’ gestation who are younger than 3 months of age at the start of the RSV season or who are born during RSV season if they have at least one of the following 2 risk factors: 1) infant attends child care; 2) infant has a sibling younger than 5 years of age
Infants and children younger than 2 years with cyanotic or complicated congenital heart disease
Infants and children younger than 2 years who have been treated for chronic lung disease within 6 months of the start of the RSV season.
Infants born before 35 weeks of gestation who have either congenital abnormalities of the airway or neuromuscular disease that compromises handling of respiratory secretions

Monday, January 30, 2012

PYLORIC STENOSIS

Pyloric stenosis is a narrowing of the pyloric outlet secondary to idiopathic hypertrophy of the pyloric muscle. It occurs in ~1/1000 births.
The male:female ratio is 5:1.
Infants usually present with vomiting
at 3-6 weeks of life.
The emesis is non-bilious and can be “projectile”.
If the vomiting is prolonged, the
infants can develop poor weight gain and dehydration (hypochloremic alkalosis). Diagnosis can be made clinically by history and physical exam. The hypertrophied pylorus can sometimes be palpated on abdominal exam (“olive”).
Pyloric sonograms and UGI series can also be helpful in making the
diagnosis.
Treatment is almost always surgical.

Sunday, January 29, 2012

Gower's sign


Gowers' sign is a medical sign that indicates weakness of the proximal muscles, namely those of the lower limb. The sign describes a patient that has to use his hands and arms to "walk" up his own body from a squatting position due to lack of hip and thigh muscle strength



Duchenne muscular dystrophy is a rapidly-worsening form of muscular dystrophy. Other muscular dystrophies (including Becker's muscular dystrophy) get worse much more slowly.
Duchenne muscular dystrophy is caused by a defective gene for dystrophin (a protein in the muscles). However, it often occurs in people without a known family history of the condition.
Because of the way the disease is inherited, males are more likely to develop symptoms than are women. The sons of females who are carriers of the disease (women with a defective gene but no symptoms themselves) each have a 50% chance of having the disease. The daughters each have a 50% chance of being carriers.
Duchenne muscular dystrophy occurs in approximately 1 out of every 3,600 male infants. Because this is an inherited disorder, risks include a family history of Duchenne muscular dystrophy.
Duchenne muscular dystrophy - PubMed Health

Saturday, January 28, 2012

Calculating Absolute Neutrophil Count


White blood cell in thousands X percentage of Neutrophil

Example:
White blood cells = 3.8 = 3800 cells
Neutrophils = 12%
The ANC is 3800 x 12/100 = 456 THIS IS SEVERE NEUTROPENIA

Clinically Significant Neutrophil Counts

Clinically Significant Neutrophil Counts
ANC (Absolute Neutrophil Counts)
Clinical Significance
>1,500/mm3 Is Normal
1,000-1,500 No significant propensity to infection. Fevers can be managed on an outpatient basis.
500-1,000 Some propensity to infection. Occasionally fever can be managed on an outpatient basis.
less than 500 Significant propensity to infection. Always should be managed as inpatient with parenteral antibiotics. Few clinical signs of infection.

These rules apply strictly for neutropenia with hypoplastic marrow, early myeloid arrest, and decreased granulocyte reserve pools.
There is more latitude for clinical judgment in neutropenias with normocellular marrow.
The exception to these rules is chronic benign neutropenia of childhood.

Thursday, January 26, 2012

Adrenoleukodystrophy

T2 weighted axial scan at the level of the caudate heads demonstrates marked loss of posterior white matter, with reduced volume and increased signal intensity. The anterior white matter is spared. Features are consistent with X-linked adrenoleukodystrophy.


X-ALD is an inherited metabolic storage disease whereby a defect in a specific enzyme results in the accumulation of very long-chain fatty acids (VLCFA) in tissues of the body, especially the brain and the adrenal glands. Ultimately the myelin sheath that surrounds the nerves is destroyed causing neurologic problems, and the adrenal gland malfunction causes Addison’s disease.


Symptoms normally start between the ages of 4 and 10 and include loss of previously acquired neurologic abilities, seizuresataxiaAddison's disease, and degeneration of visual and auditory function.



Although there is no guaranteed method for preventing X-ALD, recommend genetic counseling for prospective parents with a family history of X-ALD. Female carriers can be diagnosed 85% of the time based on blood very long chain fatty acid (VLCFA) levels and genetic testing performed by specialized laboratories.
Prenatal diagnosis of X-ALD is also available. It is done by evaluating cells from chronic villus sampling or amniocentesis

Wednesday, January 25, 2012

Rheumatic Fever



Major criteria

§         Polyarthritis: A temporary migrating inflammation of the large joints, usually starting in the legs and migrating upwards.
§         Carditis: Inflammation of the heart muscle which can manifest as congestive heart failure with shortness of breath, pericarditis with a rub, or a new heart murmur.
§         Subcutaneous nodules: Painless, firm collections of collagen fibers over bones or tendons. They commonly appear on the back of the wrist, the outside elbow, and the front of the knees.
§         Erythema marginatum: A long lasting rash that begins on the trunk or arms as macules and spreads outward to form a snake like ring while clearing in the middle. This rash never starts on the face and it is made worse with heat.
§         Sydenham’s chorea (St. Vitus’ dance): A characteristic series of rapid movements without purpose of the face and arms. This can occur very late in the disease for at least three months from onset of infection.
Minor criteria

§         Fever of 38.2–38.9 °C (101–102 °F)
§         Neuralgia: Joint pain without swelling (Cannot be included if polyarthritis is present as a major symptom)
§         Raised erythrocyte sedimentation rate or C reactive protein
§         Leukocytosis
§         ECG showing features of heart block, such as a prolonged PR interval (Cannot be included if carditis is present as a major symptom)
§         First Degree AV-Block 
§         Previous episode of rheumatic fever or inactive heart disease